跳至主要内容
临床试验/NCT05141292
NCT05141292招募中不适用

A Registry Study of Biomarkers in Mitral Valve Disease

Beijing Institute of Heart, Lung and Blood Vessel Diseases1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
5,000
试验地点
1
主要终点
Number of death (all cause)

研究概览

简要总结

The registry study aims to discover the prognostic value of bio-markers in mitral valve disease

详细描述

The purpose of this study is to investigate the prognostic value of biomarkers in mitral valve disease.Patients with confirmed diagnosis of mitral valve disease are enrolled.The primary outcome is all-cause mortality based on the death certificates. The secondary outcome is readmission for heart failure and all-cause mortality/readmission for heart failure according to the patients' medical records.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients clinically diagnosed with mitral valve disease in Beijing Anzhen Hospital from April 2016 to December 2019
  • The operator performs more than 25 mitral valve operations per year / the operator unit has surgeons who complete 50 operations per year

排除标准

  • Age ≤ 18 years
  • Failure to obtain medical records and ultrasound data
  • Refuse follow-up

结局指标

主要结局

Number of death (all cause)

时间窗: 1 years of follow-up

Number of death within 2 years of discharge

次要结局

  • Number of rehospitalizations(1 years of follow-up)

研究者

发起方
Beijing Institute of Heart, Lung and Blood Vessel Diseases
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验